1. About Hepalink
      Established in 1998 in Shenzhen, China, Hepalink is a leading multinational biopharmaceutical  company dual-listed in Hong Kong and mainland China. Driven by patient’s unmet needs, Hepalink is striving to fulfill its mission of bringing safe and effective therapies and services to patients around the world.
      1998

      years

      Established in 1998 in Shenzhen
      a+h

      stocks

      Dual-listed in Hong Kong and mainland China
      40+

      countries and regions

      With presence and business operations in over 40 countries and regions around the world